Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis

Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis

Bibliographic Details
Main Authors:	Au, Wing-Yan, Fong, Bonnie M., Tam, Sidney, Kwong, Yok-Lam
Format:	Online
Language:	English
Published:	Springer-Verlag 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567333/

Similar Items

Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
by: Chau, David, et al.
Published: (2015)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
by: Alimoghaddam, Kamran
Published: (2014)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
by: Mathews, Vikram, et al.
Published: (2011)

Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line
by: Baek, Jin Ho, et al.
Published: (2012)

Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report
by: Emmons, Gregory S, et al.
Published: (2012)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
by: Chen, Baowei, et al.
Published: (2013)

Severe Acute Axonal Neuropathy following Treatment with Arsenic Trioxide for Acute Promyelocytic Leukemia: a Case Report
by: Kühn, Marcus, et al.
Published: (2016)

Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
by: Zhou, Guang-Biao, et al.
Published: (2005)

Acute promyelocytic leukemia, arsenic, and PML bodies
by: de Thé, Hugues, et al.
Published: (2012)

Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
by: Iriyama, Noriyoshi, et al.
Published: (2012)

Successful Control of Disseminated Intravascular Coagulation by Recombinant Thrombomodulin during Arsenic Trioxide Treatment in Relapsed Patient with Acute Promyelocytic Leukemia
by: Shindo, Motohiro, et al.
Published: (2012)

Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia
by: Ganesan, S, et al.
Published: (2016)

Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report
by: Kojima, Minoru, et al.
Published: (2016)

Erythema multiforme due to arsenic trioxide in a case of acute promyelocytic leukemia: A diagnostic challenge
by: Badarkhe, Girish V., et al.
Published: (2016)

Unusual massive bone marrow fibrosis in acute promyelocytic leukemia following arsenic trioxide therapy
by: Venkatesan, S., et al.
Published: (2015)

Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells
by: Wang, Shuping, et al.
Published: (2015)

Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia
by: Liu, Cheng-cheng, et al.
Published: (2015)

Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance
by: Chendamarai, Ezhilarasi, et al.
Published: (2015)

Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia
by: Zhang, Ye, et al.
Published: (2016)

Role of Signal Regulatory Protein α in Arsenic Trioxide-induced Promyelocytic Leukemia Cell Apoptosis
by: Pan, Chaoyun, et al.
Published: (2016)

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2018-09-01)

Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
by: Li Zhang, et al.
Published: (2018-04-01)

Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide
by: Shen, Yang, et al.
Published: (2015)

Budgetary Impact of Treating Acute Promyelocytic Leukemia Patients with First-Line Arsenic Trioxide and Retinoic Acid from an Italian Payer Perspective
by: Kruse, Morgan, et al.
Published: (2015)

Deficiency of SUMO-specific protease 1 induces arsenic trioxide-mediated apoptosis by regulating XBP1 activity in human acute promyelocytic leukemia
by: Wang, Fei-Fei, et al.
Published: (2016)

Newly Diagnosed Acute Promyelocytic Leukemia
by: Avvisati, Giuseppe
Published: (2011)

Acute promyelocytic leukemia with unusual karyotype
by: Gowri, Mangala, et al.
Published: (2011)

Management of Acute Promyelocytic Leukemia in the Elderly
by: Lo-Coco, Francesco, et al.
Published: (2013)

Notch Signaling in Acute Promyelocytic Leukemia
by: Grieselhuber, Nicole R., et al.
Published: (2013)

Nephrotic syndrome in acute promyelocytic leukemia
by: Moradveisi, Borhan, et al.
Published: (2014)

hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide
by: HE, JIN-HUA, et al.
Published: (2013)

Arsenic Trioxide and Resveratrol Show Synergistic Anti-Leukemia Activity and Neutralized Cardiotoxicity
by: Fan, Yuhua, et al.
Published: (2014)

Acute Appendicitis Secondary to Acute Promyelocytic Leukemia
by: Rodriguez, Eduardo A., et al.
Published: (2015)

Survival and treatment response in adults with acute promyelocytic leukemia treated with a modified International Consortium on Acute Promyelocytic Leukemia protocol
by: Crespo-Solis, Erick, et al.
Published: (2016)

Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia
by: Lallemand-Breitenbach, Valérie, et al.
Published: (1999)

High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure
by: Smith, Morgan B., et al.
Published: (2014)

Molecular Pathogenesis of Secondary Acute Promyelocytic Leukemia
by: Joannides, M., et al.
Published: (2011)

Epidemiology and Treatment of Acute Promyelocytic Leukemia in Latin America
by: Rego, E.M., et al.
Published: (2011)

Pathogenesis and Treatment of Thrombohemorrhagic Diathesis in Acute Promyelocytic Leukemia
by: Falanga, Anna, et al.
Published: (2011)

Cellulitis with Leukocytopenia as an Initial Sign of Acute Promyelocytic Leukemia
by: Sakamoto, Sachiko, et al.
Published: (2012)